Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
1.660
0.00 (0.00%)
At close: Dec 12, 2025, 4:00 PM EST
1.660
0.00 (-0.02%)
After-hours: Dec 12, 2025, 7:37 PM EST
Akebia Therapeutics Market Cap
Akebia Therapeutics has a market cap or net worth of $440.51 million as of December 12, 2025. Its market cap has decreased by -1.52% in one year.
Market Cap
440.51M
Enterprise Value
473.07M
1-Year Change
-1.52%
Ranking
Category
Stock Price
$1.66
Market Cap Chart
Since March 20, 2014, Akebia Therapeutics's market cap has decreased from $488.10M to $440.51M, a decrease of -9.75%. That is a compound annual growth rate of -0.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 440.50M | 6.27% |
| Dec 31, 2024 | 414.50M | 77.44% |
| Dec 29, 2023 | 233.60M | 120.17% |
| Dec 30, 2022 | 106.10M | -73.17% |
| Dec 31, 2021 | 395.40M | -2.30% |
| Dec 31, 2020 | 404.70M | -46.16% |
| Dec 31, 2019 | 751.70M | 138.26% |
| Dec 31, 2018 | 315.50M | -55.11% |
| Dec 29, 2017 | 702.90M | 76.17% |
| Dec 30, 2016 | 399.00M | 0.81% |
| Dec 31, 2015 | 395.80M | 67.15% |
| Dec 31, 2014 | 236.80M | -51.49% |
| Mar 20, 2014 | 488.10M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 911.95B |
| Johnson & Johnson | 505.49B |
| AbbVie | 393.51B |
| UnitedHealth Group | 306.99B |
| AstraZeneca | 282.91B |
| Novartis AG | 251.91B |
| Merck & Co. | 245.30B |
| Novo Nordisk | 223.42B |